Siglec-6/CD327 Rekombinanter Antikörper
Siglec-6/CD327 Rekombinant Antikörper für FC
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
FC
Konjugation
Unkonjugiert
CloneNo.
243088G2
Kat-Nr. : 98416-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
98416-1-PBS bindet in FC Siglec-6/CD327 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Siglec-6/CD327 fusion protein Eg2070 |
| Vollständiger Name | sialic acid binding Ig-like lectin 6 |
| Berechnetes Molekulargewicht | 426 aa, 47 kDa |
| GenBank-Zugangsnummer | BC035359 |
| Gene symbol | SIGLEC6 |
| Gene ID (NCBI) | 946 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. |
Hintergrundinformationen
Siglec-6, also known as CD327, originally identified on trophoblast cells of the placenta, is highly and consistently expressed on MCs from both mucosal and non-mucosal sites. Siglec-6 consists of 3 extracellular immunoglobulin (Ig) domains and 2 intracellular immunoreceptor tyrosine-based inhibition motifs (ITIMs), closely resembling the molecular structure of Siglec-3 (CD33) (PMID: 34289026). Siglec-6 was recruited to placental expression during human evolution, presumably to interact with sialylated ligands for specific negative signaling functions and/or to regulate leptin availability (PMID: 17580316). Siglec-6 is an immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptor selectively expressed by mast cells, making it a promising target for therapeutic intervention (PMID: 35406705).



